| |
| | Patent 6,051,551 |
 | | The invention relates to a method of administering a fatty acid-acylated insulin or insulin analog by inhalation, a method for treating diabetes by administering a fatty acid-acylated insulin or insulin analog by inhalation, and a method for treating hyperglycemia by administering a fatty acid-acylated insulin or insulin analog by inhalation. |
 | | Second, presently known soluble, long-acting insulins and insulin derivatives are delivered by subcutaneous injection, which involves the inconvenience of preparing a sample for injection, and the pain of a needle-stick. |
 | | A method of treating diabetes or hyperglycemia, comprising administering to a patient in need thereof an effective amount of a fatty acid-acylated human insulin or a fatty acid-acylated human insulin analog by inhalation, such that the fatty-acid acylated human insulin or fatty acid-acylated insulin analog is deposited in the lungs of the patient. |
| www.pharmcast.com /Patents/041800OG/6051551_Insulin041800.htm (482 words) |
|